Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1965 1
1967 2
1968 2
1969 5
1970 3
1974 1
1975 1
1982 1
1984 2
1985 5
1986 4
1987 1
1988 2
1989 2
1990 1
1991 1
1992 5
1993 4
1994 3
1995 1
1996 1
1997 3
1998 4
1999 2
2000 4
2001 5
2002 2
2003 5
2004 2
2005 5
2006 3
2007 7
2008 7
2009 8
2010 3
2011 11
2012 7
2013 12
2014 12
2015 14
2016 9
2017 13
2018 17
2019 12
2020 11
2021 25
2022 20
2023 12
2024 20
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Among authors: solini a. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
Ciardullo S, Morieri ML, Daniele G, Fiorentino TV, Mezza T, Tricò D, Consoli A, Del Prato S, Giorgino F, Piro S, Solini A, Avogaro A. Ciardullo S, et al. Among authors: solini a. Acta Diabetol. 2024 Aug;61(8):941-950. doi: 10.1007/s00592-024-02300-6. Epub 2024 Jun 3. Acta Diabetol. 2024. PMID: 38831203 Free PMC article. Review.
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Lamacchia O, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Penno G, et al. Among authors: solini a. BMC Med. 2021 Mar 15;19(1):66. doi: 10.1186/s12916-021-01936-3. BMC Med. 2021. PMID: 33715620 Free PMC article.
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
Fadini GP, Longato E, Morieri ML, Bonora E, Consoli A, Fattor B, Rigato M, Turchi F, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Among authors: solini a. Diabetologia. 2024 Nov;67(11):2585-2597. doi: 10.1007/s00125-024-06251-z. Epub 2024 Aug 23. Diabetologia. 2024. PMID: 39177691 Free PMC article.
Extra-glycaemic properties of empagliflozin.
Solini A. Solini A. Diabetes Metab Res Rev. 2016 Mar;32(3):230-7. doi: 10.1002/dmrr.2666. Epub 2015 Jun 25. Diabetes Metab Res Rev. 2016. PMID: 25994513 Review.
275 results